Microalbuminuria in Chronic Obstructive Pulmonary Disease with and Without Co-morbidities

  • Hridyanshu VyasEmail author
  • Purvi Purohit
  • Naveen Dutt
  • Praveen Sharma
Letter to the Editor



Financial support by Dept. of Biochemistry, AIIMS Jodhpur; Dr. Purvi Purohit, Associate professor, Dept. of Biochemistry, AIIMS Jodhpur).


  1. 1.
    Siva KK, Gayathri AR. Prevalence of comorbid conditions in patients of chronic obstructive pulmonary disease (COPD) with acute exacerbation. IJSR. 2015;4(2):1847–50.Google Scholar
  2. 2.
    Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166(3):333–9.CrossRefGoogle Scholar
  3. 3.
    Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2(1):8–11.CrossRefGoogle Scholar
  4. 4.
    Celli BD, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–12.CrossRefGoogle Scholar
  5. 5.
    Kistorp C, Raymond I, Pedersen F, Gustaffson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609–16.CrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2019

Authors and Affiliations

  • Hridyanshu Vyas
    • 1
    Email author
  • Purvi Purohit
    • 2
  • Naveen Dutt
    • 3
  • Praveen Sharma
    • 2
  1. 1.AIIMSJodhpurIndia
  2. 2.Department of BiochemistryAIIMSJodhpurIndia
  3. 3.Department of Pulmonary MedicineAIIMSJodhpurIndia

Personalised recommendations